Literature DB >> 17172510

Helicobacter pylori cag pathogenicity island genes: clinical relevance for peptic ulcer disease development in Brazil.

Rejane Mattar1, Sergio Barbosa Marques1, Maria do Socorro Monteiro1, Anibal Ferreira Dos Santos1, Kiyoshi Iriya1, Flair José Carrilho1.   

Abstract

The purpose of this study was to verify whether the presence of any of the Helicobacter pylori cagPAI genes or segments--cagA, cagA promoter, cagE, cagM, tnpB, tnpA, cagT and the left end of the cag II (LEC) region--would be a useful marker for the risk of peptic ulcer disease development. H. pylori DNA extracted from positive urease tests of 150 peptic ulcer patients and 65 dyspeptic controls was analysed by PCR. Duodenal ulcers were present in 110, gastric ulcers in 23 and both gastric and duodenal ulcers in 17 patients. A significant association (P <0.001) was found between a conserved cagPAI and peptic ulcer disease (34 %). The positivity of the cagA gene varied according to the region of the gene that was amplified. The region near to the promoter was present in almost all of the H. pylori isolates (97.2 %). The segment from nt 1764 to 2083 and the extreme right end were frequently deleted in the isolates from the controls (P <0.01). The positivity of the promoter region of cagA and cagT, cagE, cagM and LEC showed a significant difference between the isolates from peptic ulcer patients and from the controls (P <0.01). Patients usually had moderate gastritis; however, the intensity of the active inflammation was higher in the peptic ulcer group (P <0.001). cagT, cagM, LEC and the right end terminus of the cagA-positive H. pylori isolates were associated with a 27-fold, 8-fold, 4-fold and 4-fold risk of peptic ulcer disease, respectively, and may be useful markers to identify individuals at higher risk of peptic ulcer disease development in Brazil.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17172510     DOI: 10.1099/jmm.0.46824-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  22 in total

1.  Infection with specific Helicobacter pylori-cag pathogenicity island strains is associated with interleukin-1B gene polymorphisms in Venezuelan chronic gastritis patients.

Authors:  Miguel Angel Chiurillo; Yeinmy H Moran; Miryan Cañas; Elvis J Valderrama; Emma Armanie
Journal:  Dig Dis Sci       Date:  2010-06-29       Impact factor: 3.199

2.  Association of LEC and tnpA Helicobacter pylori genes with gastric cancer in a Brazilian population.

Authors:  Rejane Mattar; Maria S Monteiro; Sergio B Marques; Bruno Zilberstein; Cláudio L Hashimoto; Flair J Carrilho
Journal:  Infect Agent Cancer       Date:  2010-01-11       Impact factor: 2.965

3.  Low frequency of cagA-positive Helicobacter pylori strains isolated from Iranian patients with MALT lymphoma.

Authors:  Amin Talebi Bezmin Abadi; Ali Ghasemzadeh; Ashraf Mohabati Mobarez
Journal:  Intern Emerg Med       Date:  2011-04-02       Impact factor: 3.397

4.  The autoimmune susceptibility gene, PTPN2, restricts expansion of a novel mouse adherent-invasive E. coli.

Authors:  Ali Shawki; Rocio Ramirez; Marianne R Spalinger; Paul M Ruegger; Anica Sayoc-Becerra; Alina N Santos; Pritha Chatterjee; Vinicius Canale; Jonathan D Mitchell; John C Macbeth; Casey M Gries; Michel L Tremblay; Ansel Hsiao; James Borneman; Declan F McCole
Journal:  Gut Microbes       Date:  2020-06-26

5.  The cag PAI is intact and functional but HP0521 varies significantly in Helicobacter pylori isolates from Malaysia and Singapore.

Authors:  H-M A Schmidt; S Andres; C Nilsson; Z Kovach; N O Kaakoush; L Engstrand; K-L Goh; K M Fock; D Forman; H Mitchell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-16       Impact factor: 3.267

6.  Seroprevalence of anti-Hp and anti-cagA antibodies among healthy persons in Golestan province, northeast of Iran (2010).

Authors:  Fatemeh Ghasemi Kebria; Haniye Bagheri; Shahryar Semnani; Ezatollah Ghaemi
Journal:  Caspian J Intern Med       Date:  2011

7.  Involvement of the Helicobacter pylori plasticity region and cag pathogenicity island genes in the development of gastroduodenal diseases.

Authors:  A R Pacheco; J L Proença-Módena; A I L Sales; Y Fukuhara; W D da Silveira; J L Pimenta-Módena; R B de Oliveira; M Brocchi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-17       Impact factor: 3.267

8.  Quadruple therapy for eradication of Helicobacter pylori.

Authors:  Hai-Jun Ma; Jin-Liang Wang
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

9.  Molecular analysis of Helicobacter pylori virulent-associated genes in hepatobiliary patients.

Authors:  Wongwarut Boonyanugomol; Chariya Chomvarin; Banchob Sripa; Siri Chau-In; Ake Pugkhem; Wises Namwat; Warawan Wongboot; Bandit Khampoosa
Journal:  HPB (Oxford)       Date:  2012-08-17       Impact factor: 3.647

10.  Determination of Helicobacter pylori virulence by analysis of the cag pathogenicity island isolated from Iranian patients.

Authors:  K Baghaei; L Shokrzadeh; F Jafari; H Dabiri; Y Yamaoka; M Bolfion; H Zojaji; M M Aslani; M R Zali
Journal:  Dig Liver Dis       Date:  2009-03-03       Impact factor: 4.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.